Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test

scientific article

Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1572-0241.2002.05709.X
P698PubMed publication ID12014732
P5875ResearchGate publication ID11356403

P2093author name stringFull-Young Chang
Jaw-Ching Wu
Shou-Dong Lee
Yi-Shin Huang
Jen-Huey Chiang
P2860cites workTranscatheter arterial chemoembolization as primary treatment for hepatocellular carcinomaQ40637515
Cytolysis following chemoembolization for hepatocellular carcinomaQ43464066
Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.Q51646424
Lignocaine metabolite formation as a measure of pre-transplant liver function.Q51755557
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHCQ77059950
P433issue5
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)1223-1227
P577publication date2002-05-01
P1433published inThe American Journal of GastroenterologyQ7713501
P1476titleRisk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test
P478volume97